Human medicines European public assessment report (EPAR): Dupixent, dupilumab, Date of authorisation: 26/09/2017, Revision: 49, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 18 August 2026 - 12:57

Human medicines European public assessment report (EPAR): Dupixent, dupilumab, Date of authorisation: 26/09/2017, Revision: 49, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/dupixent

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters